Metraipolis › archive › dc_57d060efc207

Serum CCL2 and CCL7 in Prostate Cancer: Evaluation of Their Diagnostic Utility in Comparison with Benign Prostatic Hyperplasia and Healthy Controls — Europe PMC PMID:42511541

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42511541
DOI
10.3390/ijms27146197
License (as archived)
solo-consultazione
Archived
2026-10-18T08:25:06.502Z
SHA-256 of the archived text
362241a155ade6df18f7f46d3b953a2a00e7f39c4c4f9772ee733ab8294035c6
Stable URL of this page
https://metraipolis.com/documento/dc_57d060efc207

How to cite

Serum CCL2 and CCL7 in Prostate Cancer: Evaluation of Their Diagnostic Utility in Comparison with Benign Prostatic Hyperplasia and Healthy Controls — Europe PMC PMID:42511541 — Europe PMC (en), https://europepmc.org/article/MED/42511541 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57d060efc207 (Metraipolis archive dc_57d060efc207, sha256 362241a155ade6df18f7f46d3b953a2a00e7f39c4c4f9772ee733ab8294035c6)
BibTeX
@misc{dc57d060efc207,
  title = {Serum CCL2 and CCL7 in Prostate Cancer: Evaluation of Their Diagnostic Utility in Comparison with Benign Prostatic Hyperplasia and Healthy Controls — Europe PMC PMID:42511541},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42511541},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57d060efc207; sha256 362241a155ade6df18f7f46d3b953a2a00e7f39c4c4f9772ee733ab8294035c6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42511541. Agents can read the archived copy with the MCP tool read_document.